Anebulo Pharmaceuticals Inc — Balance Sheet (NASDAQ:ANEB) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Total assets 21.65 M15.58 M11.67 M4.07 M12.15 M Total liabilities 241.63 K512.53 K1.07 M260.58 K487.69 K Total equity 21.41 M15.07 M10.6 M3.81 M11.66 M Total liabilities & shareholders' equities 21.65 M15.58 M11.67 M4.07 M12.15 M Total debt ————— Net debt —————

Nachrichten

Anebulo Pharmaceuticals: Aktie bricht nach Ankündigung des NASDAQ-Delistings ein

Anebulo Pharmaceuticals stock plunges after announcing Nasdaq delisting plans

Anebulo Pharmaceuticals to delist from Nasdaq, deregister with SEC

Anebulo completes oversubscribed share repurchase tender offer

Anebulo Pharmaceuticals verwirft Reverse Split – Aktie stürzt ab

Anebulo Pharmaceuticals stock plunges after scrapping reverse split plan

Anebulo shifts from reverse stock split to tender offer in go-private plan

Crude Oil Jumps 2%; Chicago Fed National Activity Index Improves Slightly In September - Adeia (NASDAQ:ADEA), Anebulo Pharmaceuticals (NASDAQ:ANEB)

US Stocks Higher; Nasdaq Surges Over 100 Points - Anebulo Pharmaceuticals (NASDAQ:ANEB), EUDA Health Holdings (NASDAQ:EUDA)

Anebulo startet Phase-1-Studie zur Behandlung von Cannabis-Toxizität

Anebulo begins phase 1 trial of IV cannabis toxicity treatment

Nach Delisting-Plan: Anebulo Pharmaceuticals prüft strategische Alternativen/n